Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | USP2 | O75604 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | FTO | Q9C0B1 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.38 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1703820 | 0.95 | MAPT (0.59) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL5445148 | 0.89 | MEN1 (0.68) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL4632262 | 0.87 | MEN1 (0.49) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL7575984 | 0.85 | MAPT (0.60) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL18009919 | 0.83 | MAPT (0.66) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL3248111 | 0.82 | GSTP1 (0.67) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL19549151 | 0.82 | MEN1 (0.42) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL1029702 | 0.81 | ALDH1A1 (0.67) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL6523127 | 0.80 | MAPT (0.62) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL9561179 | 0.80 | ALDH1A1 (0.62) | MAPTMEN1KMT2AALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024117691-A1 | GOLD NANOZYME COMPRISING GLYCOL CHITOSAN AND GOLD PARTICLES, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING SAME | 한양대학교 산학협력단 | 2024-06-06 | — | — | WO | disclosed |
| US-20230407238-A1 | USE OF HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE IN STABILIZING ERGOTHIONEINE, AND ERGOTHIONEINE COMPOSITION CONTAINING HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE | BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED (CN) | 2023-12-21 | — | — | US | disclosed |
| CN-114904012-B | Active oxygen self-supplementing amphiphilic block copolymer-drug conjugate, preparation method and application thereof | 四川大学华西医院 | 2023-12-15 | — | — | CN | disclosed |
| EP-4245304-A1 | USE OF HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE IN STABILIZING ERGOTHIONEINE, AND ERGOTHIONEINE COMPOSITION CONTAINING HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE | Bloomage Biotechnology Corporation Limited (CN) | 2023-09-20 | — | — | EP | disclosed |
| CN-114904012-A | Active oxygen self-complementary amphiphilic block copolymer-drug conjugate, preparation method and application thereof | 四川大学华西医院 | 2022-08-16 | — | — | CN | disclosed |
| US-20200316129-A1 | ENGINEERED ANUCLEATE CELLULAR AND EXTRACELLULAR VESICLES AS A NOVEL BIOLOGICS DELIVERY PLATFORM | THE JOHNS HOPKINS UNIVERSITY | 2020-10-08 | — | — | US | disclosed |
| WO-2017205559-A1 | ENGINEERED ANUCLEATE CELLULAR AND EXTRACELLULAR VESICLES AS A NOVEL BIOLOGICS DELIVERY PLATFORM | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-11-30 | — | — | WO | disclosed |
| CN-106794123-A | The composition of the material of the expression comprising regulation ABH antigens | 株式会社爱茉莉太平洋 | 2017-05-31 | — | — | CN | disclosed |
| US-20160375107-A1 | FRAGILE HISTIDINE TRIAD (FHIT) COMPOSITIONS AND USES THEREOF | THE OHIO STATE UNIVERSITY (US) | 2016-12-29 | — | — | US | disclosed |
| EP-2428208-B1 | Method of determining the potency of pharmaceutical substances to reduce the cellular glutathion content and to increase the cellular ROS content | EBERHARD KARLS UNIVERSITÄT TÜBINGEN UNIVERSITÄTSKLINIKUM (DE) | 2016-11-30 | — | — | EP | disclosed |
| WO-2009122447-A1 | SEMI-SYNTHETIC SESQUITERPENE LACTONE PARTHENIN COMPOUND USEFUL FOR CYTOTOXICITY AGAINST CANCER CELL LINES AND ANTICANDER AGENT | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2009-10-08 | — | — | WO | disclosed |
| EP-2104533-A2 | USE OF SUBSTANCES REDUCING CELLULAR GLUTATHIONE CONTENT FOR PRODUCING A MEDICAMENT FOR TREATING T-CELL MEDIATED AUTOIMMUNE DISEASES | Eberhard-Karls-Universität Tübingen (DE) | 2009-09-30 | — | — | EP | disclosed |
| WO-2009055773-A2 | METHODS FOR IDENTIFYING FRAGILE HISTIDINE TRIAD (FHIT) INTERACTION AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-04-30 | — | — | WO | disclosed |
| WO-2008064756-A2 | USE OF SUBSTANCES REDUCING CELLULAR GLUTATHIONE CONTENT FOR PRODUCING A MEDICAMENT FOR TREATING T-CELL MEDIATED AUTOIMMUNE DISEASES | Eberhard-Karls-Universität Tübingen (DE) | 2008-06-05 | — | — | WO | disclosed |
| EP-0723778-B1 | Composition for induction of apoptosis comprising a factor increasing the intracellular level of methional or malondialdehyde | INT DE CENTRE (FR) | 2000-04-05 | — | — | EP | disclosed |
| WO-1999033463-A9 | SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b) | MOSER RENE (CH) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999033463-A1 | SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b) | Moser, René (CH) | 1999-07-08 | — | — | WO | disclosed |
| US-5744499-A | Apoptosis-modulating factors influencing the intracellular concentration of methional/malondialdehyde | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1998-04-28 | — | — | US | disclosed |
| EP-0723778-A1 | Composition for modulation of apoptosis comprising a factor influencing the intracellular level of methional or malondialdehyde | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 1996-07-31 | — | — | EP | disclosed |
| WO-1996020701-A1 | APOPTOSIS-MODULATING COMPOSITION COMPRISING A FACTOR AFFECTING THE INTRACELLULAR RATE OF METHIONAL OR MALONDIALDEHYDE | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 1996-07-11 | — | — | WO | disclosed |